No definition available.
Viral encephalitis, not elsewhere classified/unspecified
AB1_VIRAL_ENCEPHALITIS_NOS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
855 |
4. Check minimum number of eventsNone |
855 |
5. Include endpointsNone |
855 |
6. Filter based on genotype QC (FinnGen only) |
762 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Viral encephalitis, not elsewhere classified/unspecified
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system
- Viral infections of the central nervous system, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6491 | 3070 | 3393 |
| Only index persons | 5729 | 2699 | 3030 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.09 | 0.09 |
| Only index persons | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 52.94 | 56.53 | 49.53 |
| Only index persons | 52.07 | 55.63 | 48.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 762 | 396 | 366 |
| Unadjusted period prevalence (%) | 0.15 | 0.14 | 0.17 |
| Median age at first event (years) | 57.48 | 54.66 | 60.53 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 788
- Matched controls
- 7880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
307.7
729
*
TAB00
NOMESCO Finland
Lumbar puncture
19.4
265.6
232
166
N03AX14
ATC
levetiracetam; systemic
13.6
108.6
107
90
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.8
102.8
190
353
AA1AD
NOMESCO Finland
CT of head and brain
4.7
102.7
424
1562
XA800
NOMESCO Finland
Neuropsychological investigation
9.6
97.2
124
151
R41.0
ICD-10 Finland
Disorientation, unspecified
11.1
97.1
110
114
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.6
96.6
136
187
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.3
93.1
135
192
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.4
88.2
97
96
A87.9
ICD-10 Finland
Viral meningitis, unspecified
+∞
74.1
70
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.8
70.4
94
120
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.7
68.8
73
68
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
179.8
64.0
66
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.7
59.7
63
58
F05.9
ICD-10 Finland
Delirium, unspecified
10.4
58.2
67
70
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
53.3
249
925
N03AF02
ATC
oxcarbazepine; oral
7.7
51.2
75
106
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.3
50.9
155
429
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.3
47.9
55
57
A85.8
ICD-10 Finland
Other specified viral encephalitis
+∞
46.3
44
*
Z2445
NOMESCO Finland
Psychologist
6.0
44.0
82
149
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
43.1
41
*
5AB01, ,
NOMESCO Finland
95.4
41.2
45
5
R50.9
ICD-10 Finland
Fever, unspecified
3.2
39.2
194
732
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
38.3
192
729
N03AG01
ATC
valproic acid; systemic, rectal
4.3
33.9
95
244
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
32.5
199
837
R4120
NOMESCO Finland
Occupational therapy
3.9
30.2
95
265
R51.80
ICD-10 Finland
Headache
2.8
29.2
181
762
183
Kela drug reimbursment
Lamotrigin and topiramate
11.1
27.9
30
28
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.2
27.4
124
438
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
27.1
136
509
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
27.0
274
1452
WX730
NOMESCO Finland
Conventional respirator
10.0
26.0
30
31
WX892
NOMESCO Finland
Monitored bed care
3.4
26.0
100
319
XA400
NOMESCO Finland
EEG
28.1
26.0
35
13
N03AX18
ATC
lacosamide; systemic
22.8
25.9
37
17
G03.9
ICD-10 Finland
Meningitis, unspecified
50.1
24.4
29
6
ZX120
NOMESCO Finland
Intravenous
3.1
23.7
112
404
G41.9
ICD-10 Finland
Status epilepticus, unspecified
29.3
23.3
31
11
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.9
23.1
36
54
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
23.0
22
*
N71
ICPC
Meningitis/encephalitis
236.6
22.7
23
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
22.1
54
124
N03AB02
ATC
phenytoin; systemic
7.2
21.3
32
46
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
20.3
416
2816
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
19.9
19
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
19.3
211
1129
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
17.3
19.3
30
18
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.1
19.2
26
33
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
18.8
18
*
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
17.8
17
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
17.2
79
279
B00.4
ICD-10 Finland
Herpesviral encephalitis
173.5
16.6
17
*
R11
ICD-10 Finland
Nausea and vomiting
2.6
16.0
97
398
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
15.9
130
613
N05BA09
ATC
clobazam; oral
16.5
15.3
24
15
N03AF01
ATC
carbamazepine; oral, rectal
3.3
15.2
59
188
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
15.2
85
334
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.6
14.9
27
24
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
14.6
14
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
14.1
108
493
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
4.6
13.9
33
74
Z3231
NOMESCO Finland
Registered nurse
1.9
13.9
231
1415
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
13.7
145
756
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
13.6
13
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
40.8
13.2
16
*
N28
ICPC
Limited function/disability (N)
5.3
13.0
26
50
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.0
12.9
28
58
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
12.8
142
753
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.9
12.8
25
26
N05BA01
ATC
diazepam; systemic, rectal
2.2
12.7
118
584
J05AB11
ATC
valaciclovir; oral
2.1
12.7
135
705
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
132.0
12.5
13
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
12.4
164
925
N05AH04
ATC
quetiapine; oral
2.0
12.4
160
896
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.2
12.3
25
49
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
12.1
73
298
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
12.1
44
135
N03AX16
ATC
[U] pregabalin
1.9
12.0
187
1115
N29
ICPC
Neurological sympt/complt other
4.6
12.0
28
62
R53
ICD-10 Finland
Malaise and fatigue
1.8
11.9
222
1398
R42
ICD-10 Finland
Dizziness and giddiness
1.9
11.9
193
1164
E86
ICD-10 Finland
Volume depletion
4.0
11.9
34
88
N03AX09
ATC
lamotrigine; oral
3.0
11.7
53
186
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.4
11.7
43
133
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.8
11.6
24
28
A28
ICPC
Limited function/disability NOS
1.9
11.6
159
908
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
11.5
11
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
121.7
11.5
12
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
11.4
111
559
H02AB06
ATC
prednisolone; systemic
1.7
11.4
374
2754
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.4
11.3
80
352
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
11.0
61
238
Z3226
NOMESCO Finland
Physiotherapist
1.9
11.0
151
860
N03AE01
ATC
clonazepam; systemic
2.8
10.9
54
199
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
10.9
100
492
R4110
NOMESCO Finland
Physiotherapy
1.8
10.8
224
1450
F05.8
ICD-10 Finland
Other delirium
9.8
10.8
21
22
Z2221
NOMESCO Finland
Medical doctor
1.8
10.8
216
1385
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.2
10.8
44
145
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
18.1
10.8
16
9
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
10.4
84
391
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
10.4
10
*
L28
ICPC
Limited function/disability (L)
1.9
10.3
158
933
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.3
239
1596
R25.1
ICD-10 Finland
Tremor, unspecified
3.7
10.2
32
89
C03CA01
ATC
furosemide; systemic
1.7
10.1
246
1663
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
40.6
10.0
12
*
N30.0
ICD-10 Finland
Acute cystitis
1.9
9.9
138
789
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
9.9
275
1922
N05CF01
ATC
zopiclone; oral
1.7
9.8
252
1723
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
9.6
116
632
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.7
9.6
22
48
N05AX08
ATC
risperidone; systemic
2.2
9.6
87
426
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
9.5
66
288
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.6
9.5
56
226
A87.8
ICD-10 Finland
Other viral meningitis
+∞
9.4
9
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.8
9.3
21
45
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.1
337
2513
N06AX11
ATC
mirtazapine; oral
1.6
9.1
268
1893
Z2446
NOMESCO Finland
Social worker
2.4
9.1
63
275
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.0
223
1504
N05BA04
ATC
oxazepam; oral
1.7
9.0
211
1403
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
9.0
26
68
G40
ICD-10 Finland
Epilepsy
8.1
8.9
19
24
N05AA02
ATC
levomepromazine; systemic
3.0
8.9
40
140
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
8.8
31
93
N06AB04
ATC
citalopram; systemic
1.8
8.8
164
1025
B02.0
ICD-10 Finland
Zoster encephalitis
50.6
8.7
10
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.6
8.6
20
44
5CM18, ,
NOMESCO Finland
11.7
8.6
15
13
J01DB01
ATC
cefalexin; oral
1.7
8.5
635
5559
R1260
NOMESCO Finland
Evaluation of communicative skills
4.1
8.4
23
58
JN4BD
NOMESCO Finland
Extensive body CT
2.1
8.4
85
434
J01MA12
ATC
levofloxacin; systemic
1.8
8.4
147
901
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
8.2
21
50
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
6.4
8.0
20
32
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
8.0
42
160
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
8.0
145
897
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
8.0
78
393
N06AX16
ATC
venlafaxine; oral
1.9
7.9
114
657
R4130
NOMESCO Finland
Speech therapy
3.2
7.9
30
95
SPAT1254
SPAT
Administration of medicine
1.8
7.9
120
704
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
7.8
31
101
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
15.2
7.7
12
8
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.0
7.7
20
34
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.7
289
2143
N99
ICPC
Neurological disease other
6.8
7.6
18
27
A02BC02
ATC
pantoprazole; systemic
1.5
7.5
509
4276
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
7.4
55
247
C07AB07
ATC
bisoprolol; oral
1.5
7.4
363
2844
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.3
271
1998
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
11.0
7.3
13
12
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
7.3
50
217
A04
ICPC
Weakness/tiredness general
1.8
7.3
126
767
F03
ICD-10 Finland
Unspecified dementia
2.6
7.3
41
162
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.8
7.3
36
133
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.7
7.3
37
139
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
7.2
77
400
N03AX11
ATC
topiramate; oral
3.3
7.2
26
80
G41.2
ICD-10 Finland
Complex partial status epilepticus
30.3
7.2
9
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
7.1
170
1129
H02AB07
ATC
prednisone; oral
1.8
7.1
105
609
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
7.1
64
312
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.1
112
664
TK800
NOMESCO Finland
Hemodialysis
3.7
7.1
22
61
ZXY02
NOMESCO Finland
Neuropsychologist
10.1
7.0
13
13
H02AB04
ATC
methylprednisolone; systemic
1.8
6.9
111
660
N03AX12
ATC
[U] gabapentin; oral
1.7
6.9
123
755
N05AH03
ATC
olanzapine; systemic
2.2
6.9
56
262
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
6.9
87
480
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
6.9
91
510
L01BA01
ATC
methotrexate; systemic
3.0
6.6
29
100
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
6.0
6.6
17
29
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.6
6.6
36
140
H02AB09
ATC
hydrocortisone; systemic
3.2
6.6
25
79
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.6
247
1818
R55
ICD-10 Finland
Syncope and collapse
1.9
6.6
91
517
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.8
6.6
33
123
N06AB10
ATC
escitalopram; oral
1.6
6.5
153
1012
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
70.4
6.4
7
*
A10AB05
ATC
insulin aspart; parenteral
2.0
6.4
66
339
N06AX21
ATC
duloxetine; oral
1.8
6.4
90
514
A06AD11
ATC
lactulose; oral
1.7
6.4
114
700
H3603, E103,
ICD-10 Finland
8.2
6.3
13
16
WW200
NOMESCO Finland
Immunization
3.2
6.3
24
76
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.6
6.3
17
31
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.2
6.3
49
226
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.3
6
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
6.2
64
329
WX882
NOMESCO Finland
High dependency care
2.9
6.1
27
94
G93.4
ICD-10 Finland
Encephalopathy, unspecified
12.6
6.1
10
8
N03AX23
ATC
brivaracetam; systemic
12.6
6.1
10
8
G40.89
ICD-10 Finland
Other epilepsy
10.1
6.0
11
11
B03XA02
ATC
darbepoetin alfa; parenteral
3.4
6.0
21
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
280
169
25.15
307.65
1.6
1.4
717.80
455.32
mg/l
8.76
271
162
279
149
28.44
307.65
1.5
1.4
3.82
3.74
mmol/l
0.32
263
141
185
34
70.80
307.65
1.3
1.1
—
—
—
0
0
228
66
48.20
307.65
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
166
35
59.82
291.74
1.3
1.1
—
—
—
0
0
227
148
21.14
272.77
1.8
1.5
513.75
886.81
e6/l
0.20
197
114
225
146
21.17
270.92
1.7
1.4
49.69
10.84
e6/l
3.90
189
106
138
28
59.54
243.42
1.3
1.2
—
—
—
0
0
125
27
54.84
217.14
1.5
1.4
—
—
—
0
0
138
50
33.25
208.71
1.2
1.0
—
—
—
0
0
98
15
74.47
180.81
1.2
1.1
—
—
—
0
0
93
17
61.89
166.20
1.3
1.1
—
—
—
0
0
93
17
61.89
166.20
1.3
1.1
—
—
—
0
0
85
17
55.92
149.03
1.4
1.1
—
—
—
0
0
83
23
40.22
134.72
1.2
1.1
—
—
—
0
0
213
425
6.50
107.56
2.6
2.5
18.43
22.24
au/ml
0.14
14
43
100
85
13.33
100.64
1.3
1.1
—
—
—
0
0
197
388
6.44
100.36
1.5
1.3
62.84
46.60
au/ml
—
9
30
53
10
56.75
93.32
1.4
1.2
—
—
—
0
0
91
76
13.41
92.42
1.5
2.0
—
—
—
0
0
47
11
45.37
78.89
1.2
1.0
—
—
—
0
0
119
181
7.57
76.87
1.3
1.1
—
4.51
—
0
24
115
170
7.75
76.18
1.8
3.2
27.73
33.57
umol/l
1.46
96
155
60
9
71.96
52.98
1.4
1.2
—
—
—
0
0
43
25
18.14
52.66
1.2
1.0
—
—
—
0
0
62
69
9.67
51.36
1.6
2.1
—
—
—
0
0
47
41
12.13
45.97
1.3
1.0
—
—
—
0
0
47
46
10.80
42.58
1.6
1.1
63.01
45.96
mg/l
0.75
42
36
47
47
10.57
41.94
1.1
1.2
—
—
—
0
0
44
6
77.34
39.33
1.3
1.2
—
—
—
0
0
390
2128
2.65
39.15
3.4
2.1
225.43
272.42
u/l
0.34
374
2027
45
8
59.52
38.73
1.3
1.1
—
—
—
0
0
91
204
4.91
38.61
1.3
1.3
—
—
—
0
0
43
6
75.51
38.33
1.3
1.2
—
—
—
0
0
37
36
10.73
33.56
1.6
1.2
0.54
0.50
ratio
0.66
24
19
256
1209
2.66
33.48
2.2
1.9
—
—
—
0
0
35
32
11.40
33.08
1.5
1.0
2.15
1.14
u/l
0.54
17
19
234
1082
2.65
31.69
2.4
2.1
29.75
29.47
s
0.30
227
1051
33
31
11.07
30.61
1.3
1.0
1704.52
1538.61
miu/ml
0.26
33
31
201
909
2.63
28.07
2.2
1.8
—
—
—
0
0
30
7
44.42
24.72
1.3
1.0
—
—
—
0
0
186
860
2.52
24.47
2.3
1.9
—
—
—
0
0
30
8
38.91
24.08
1.3
1.0
—
—
—
0
0
225
1156
2.32
23.27
3.7
3.5
0.80
0.82
mmol/l
1.67
208
1098
550
4010
2.23
23.25
7.7
5.3
6.96
6.68
mmol/l
1.84
530
3796
461
3158
2.11
22.65
16.1
15.1
1.25
1.26
inr
0.34
395
2630
191
927
2.40
22.41
8.6
6.4
1.01
1.05
mmol/l
1.31
177
858
33
47
7.28
22.19
1.6
2.0
241.29
193.76
e6/l
0.55
28
38
136
569
2.68
21.78
4.4
2.8
9.58
10.75
g/l
2.50
128
528
163
749
2.48
21.49
4.7
4.1
5.86
5.74
kpa
0.77
157
725
483
3419
2.07
21.08
10.4
7.5
1.21
1.21
mmol/l
0.42
426
2955
32
48
6.91
20.54
1.7
2.0
613.11
561.22
e6/l
0.18
27
36
155
723
2.42
19.64
4.8
4.2
1.64
1.75
mmol/l
0.14
137
611
576
4422
2.12
19.28
6.8
4.7
4676.45
2078.61
e6/l
0.23
11
76
494
3591
2.01
19.21
7.3
6.8
10.63
11.81
umol/l
2.39
473
3428
139
623
2.49
19.18
9.9
7.7
8.16
9.91
mmol/l
3.06
130
596
141
638
2.47
19.06
4.3
3.6
4.84
4.52
kpa
0.84
136
615
429
2993
1.95
18.54
6.7
5.2
34.37
35.74
g/l
5.06
407
2829
263
1550
2.05
18.54
3.1
2.7
4.28
5.68
e6/l
1.09
241
1407
22
5
45.15
18.31
1.4
1.0
—
—
—
0
0
74
243
3.26
18.23
2.2
1.8
—
—
—
0
0
436
3088
1.92
17.70
10.2
6.8
1.21
1.21
mmol/l
0.58
412
2849
305
1926
1.95
17.44
4.2
3.3
0.32
0.40
e6/l
0.50
240
1389
277
1699
1.97
17.20
5.5
4.2
87.73
88.85
%
0.31
267
1673
44
106
4.34
16.93
4.8
6.0
367.50
370.73
umol/l
0.05
38
96
513
3875
1.93
16.68
11.9
10.0
4.42
4.11
e9/l
2.01
454
3373
61
190
3.40
16.34
1.6
1.6
—
—
—
0
0
123
563
2.40
16.07
3.6
2.9
65.77
66.74
g/l
0.63
108
524
21
8
26.91
15.65
1.8
1.3
—
—
—
0
0
55
165
3.51
15.60
1.4
1.5
—
—
—
0
0
26
42
6.37
15.55
3.0
2.1
—
—
—
0
0
334
2242
1.85
15.33
4.5
3.4
29.30
73.84
e6/l
0.82
270
1695
197
1145
1.96
13.85
1.8
1.7
1121.57
1182.41
nmol/l
0.40
154
869
46
134
3.58
13.64
1.5
1.4
—
—
—
0
0
46
134
3.58
13.64
1.5
1.4
—
—
—
0
0
372
2661
1.75
13.20
5.7
3.9
28.20
66.99
ng/l
1.12
282
1893
64
234
2.89
13.08
2.7
1.5
0.22
0.23
g/l
0.38
58
226
614
5092
1.93
13.08
10.7
8.3
77.24
80.27
u/l
1.04
591
4826
313
2137
1.77
13.03
3.1
2.6
56.55
98.97
u/l
0.59
289
1995
109
523
2.26
12.66
1.9
1.7
—
—
—
0
0
24
44
5.59
12.65
1.0
1.0
328.94
281.50
ng/l
0.25
16
30
24
44
5.59
12.65
1.0
1.0
628.14
622.23
ng/l
0.02
14
31
24
44
5.59
12.65
1.0
1.0
42.01
37.26
ng/l
0.16
16
29
65
246
2.79
12.47
2.0
3.1
—
—
—
0
0
64
242
2.79
12.30
2.7
1.5
1.12
1.19
g/l
0.95
59
232
147
807
2.01
12.02
7.9
8.5
0.37
0.85
mmol/l
0.60
125
667
96
446
2.31
12.01
1.8
1.7
—
—
—
0
0
53
183
3.03
11.99
1.5
1.6
—
—
—
0
0
304
2103
1.73
11.79
3.3
3.3
1320.37
1393.01
ng/l
0.16
254
1800
327
2308
1.71
11.79
3.8
3.5
2.33
2.35
mmol/l
2.61
285
2107
146
820
1.96
11.13
7.8
8.4
12.16
12.18
kpa
0.01
138
791
146
820
1.96
11.13
7.8
8.4
5.00
5.09
kpa
0.47
138
788
128
688
2.03
11.05
2.2
2.0
383.43
384.36
nmol/l
0.02
122
641
41
128
3.32
10.96
1.2
1.1
—
16.60
—
0
40
14
5
28.46
10.75
1.1
1.0
—
—
—
0
0
30
79
3.91
10.29
1.2
1.2
—
—
—
0
0
83
387
2.28
10.27
1.7
1.5
—
—
—
0
0
190
1195
1.78
10.05
3.8
3.0
1.50
1.06
e6/l
1.03
108
613
321
2333
1.63
9.87
3.7
3.5
33.25
32.83
u/l
0.05
303
2218
42
144
3.02
9.64
1.6
1.5
—
—
—
0
0
50
191
2.73
9.44
1.5
1.6
—
—
—
0
0
138
801
1.88
9.44
4.7
4.4
228.84
257.69
u/l
1.48
129
754
118
652
1.95
9.35
3.3
2.5
29.92
32.22
u/l
0.33
97
557
87
441
2.09
8.74
4.5
4.0
1.90
1.71
mmol/l
0.19
62
335
163
1026
1.74
8.46
3.3
2.6
20.70
22.75
%
1.41
144
963
172
1102
1.72
8.37
3.3
2.6
2.25
2.29
g/l
0.38
153
1023
36
123
3.02
8.33
1.4
1.8
—
—
—
0
0
540
4548
1.60
8.28
4.3
3.4
52.88
48.56
u/l
0.53
510
4293
13
9
14.66
8.22
1.5
1.3
—
—
—
0
0
381
2988
1.53
7.89
2.4
2.1
92.03
95.21
pmol/l
0.68
217
1600
21
52
4.12
7.84
1.3
1.6
—
—
—
0
0
95
519
1.94
7.75
4.7
4.0
5.18
5.12
kpa
0.27
88
504
256
1846
1.57
7.71
2.3
2.3
2.80
2.92
mg/l
0.39
216
1598
77
392
2.07
7.65
5.2
3.3
0.67
0.62
%
0.79
77
392
29
93
3.20
7.47
1.4
1.6
—
—
—
0
0
7
0
+∞
7.30
1.3
0.0
—
—
—
0
0
37
139
2.74
7.25
1.5
1.5
—
—
—
0
0
28
90
3.19
7.20
9.6
8.1
8.02
6.97
mmol/l
0.75
23
74
64
313
2.14
7.06
1.5
2.0
1.63
1.49
g/l
0.53
53
283
59
281
2.19
6.96
2.3
2.0
0.93
2.65
ug/l
0.91
49
247
443
3649
1.49
6.88
5.5
3.9
0.00
0.43
estimate
0.51
99
720
440
3620
1.49
6.87
5.4
3.9
9.69
6.46
estimate
0.12
111
775
112
672
1.78
6.79
2.3
2.5
0.22
0.21
g/l
0.87
104
626
129
807
1.72
6.76
3.0
2.9
9.83
8.24
umol/l
0.29
110
723
436
3588
1.48
6.75
5.5
3.8
0.00
0.00
estimate
-0.00
108
759
174
1181
1.61
6.65
3.3
2.6
11.55
12.99
umol/l
2.18
155
1103
59
287
2.14
6.61
1.8
2.3
32.04
39.42
u/l
2.32
50
257
236
1722
1.53
6.56
3.6
2.9
349.67
348.13
umol/l
0.08
212
1518
45
196
2.37
6.55
1.4
1.2
24.33
2.68
u/ml
—
6
19
31
112
2.84
6.55
1.3
1.6
—
—
—
0
0
45
197
2.36
6.48
1.4
1.3
9.71
10.44
u/ml
—
9
33
566
4935
1.52
6.41
6.1
4.3
13.99
11.87
mm/h
2.26
535
4606
165
1122
1.60
6.22
4.1
3.1
3.94
2.20
e6/l
0.72
84
541
38
157
2.49
6.20
1.5
1.2
48.00
52.79
u/ml
—
5
16
17
44
3.93
6.01
1.2
1.6
—
—
—
0
0
41
180
2.35
5.88
1.7
2.5
12.51
12.10
mg/l
0.08
36
166
56
280
2.08
5.87
3.9
2.0
6.93
6.85
iu/ml
0.01
14
67
189
1344
1.53
5.82
4.7
4.0
107.88
333.51
ng/l
2.82
149
1041
34
138
2.53
5.77
1.4
1.5
—
—
—
0
0
47
221
2.20
5.75
1.7
1.4
0.03
0.04
iu/ml
—
6
39
26
92
2.89
5.72
1.5
1.5
—
—
—
0
0
225
1668
1.49
5.67
3.1
2.4
—
—
—
0
0
186
1330
1.52
5.56
3.2
3.0
2.45
2.45
mmol/l
0.16
159
1209
201
1463
1.50
5.52
1.9
1.4
2.21
2.44
g/l
1.11
131
908
43
200
2.22
5.41
4.5
3.7
3.64
2.82
ratio
0.25
30
119
37
163
2.33
5.29
1.7
1.5
—
—
—
0
0
21
69
3.10
5.25
1.5
1.4
59.73
55.98
%
0.16
15
50
52
264
2.04
5.25
2.0
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
42
198
2.18
5.13
2.8
2.7
0.43
0.36
iu/ml
0.45
22
101
258
2003
1.43
5.01
1.9
1.7
20.32
20.45
nmol/l
0.05
222
1696
45
224
2.07
4.80
4.9
3.9
31.07
41.50
mg/l
0.48
36
190
45
224
2.07
4.80
4.9
3.9
60.79
78.09
mg/l
0.22
36
190
18
57
3.21
4.79
1.3
1.1
—
—
—
0
0
126
858
1.56
4.66
1.8
1.8
1.70
1.47
%
1.51
106
750
18
58
3.15
4.66
1.2
1.1
—
—
—
0
0
18
58
3.15
4.66
1.2
1.1
—
—
—
0
0
46
235
2.02
4.59
3.3
2.5
9.88
10.70
g/l
0.50
39
212
44
223
2.03
4.49
1.5
1.3
—
—
—
0
0
19
65
2.97
4.47
1.5
1.7
—
—
—
0
0
19
65
2.97
4.47
1.5
1.7
—
—
—
0
0
19
65
2.97
4.47
1.5
1.7
—
—
—
0
0
84
525
1.67
4.41
5.0
4.1
91.11
83.57
ng/l
0.29
68
470
17
55
3.14
4.38
1.2
1.1
—
—
—
0
0
38
184
2.12
4.38
3.4
3.0
1.86
1.59
mmol/l
0.78
38
177
67
396
1.76
4.30
2.7
3.5
4.31
4.57
pmol/l
1.32
59
354
206
1574
1.42
4.27
2.0
1.7
0.95
1.34
mg/l
1.91
162
1222
30
133
2.31
4.27
1.3
1.3
116.50
159.06
au/ml
1.17
12
42
15
39
3.90
4.21
1.3
1.6
—
—
—
0
0
42
215
2.01
4.19
1.3
1.4
—
—
—
0
0
21
79
2.70
4.18
2.6
1.8
88.80
90.18
%
0.31
21
79
18
63
2.90
4.08
1.2
1.1
—
—
—
0
0
36
176
2.10
4.06
1.7
1.7
—
—
—
0
0
86
553
1.62
4.05
2.7
2.5
4.51
7.43
ug/l
1.85
72
495
250
1990
1.38
4.04
4.9
3.3
0.00
0.05
estimate
0.72
93
608
19
69
2.80
4.04
1.3
1.2
—
—
—
0
0
371
3143
1.34
3.99
3.5
2.8
—
—
estimate
—
0
0
18
64
2.85
3.98
4.3
3.5
12.69
12.96
index
0.06
13
45
82
525
1.63
3.93
9.2
3.9
1.22
1.23
mmol/l
0.43
75
454
13
32
4.11
3.91
1.8
2.1
2.33
1.83
umol/l
1.16
13
25
21
82
2.60
3.91
1.4
1.2
—
—
—
0
0
14
37
3.83
3.91
1.3
1.6
—
—
—
0
0
358
3025
1.34
3.89
3.0
2.5
77.66
76.51
nmol/l
0.33
325
2719
16
55
2.95
3.75
1.1
1.4
1.15
1.25
promille
0.08
11
43
31
148
2.14
3.73
1.3
1.3
368.70
261.45
u/ml
0.53
23
80
13
34
3.87
3.70
1.4
1.9
—
—
—
0
0
13
34
3.87
3.70
1.4
1.9
—
—
—
0
0
13
34
3.87
3.70
1.4
1.9
—
—
—
0
0
13
34
3.87
3.70
1.4
1.9
—
—
—
0
0
34
169
2.06
3.70
1.6
1.4
16269.78
10942.45
e6/l
0.43
27
119
18
67
2.73
3.68
3.0
3.0
—
—
—
0
0
182
1395
1.40
3.66
1.7
1.7
429.58
22700354.61
pmol/l
1.16
155
1163
326
2738
1.33
3.61
5.6
3.7
0.03
0.03
estimate
0.06
93
635
34
172
2.02
3.54
3.2
2.3
128.33
127.73
g/l
0.05
27
143
6
6
10.06
3.50
1.0
3.5
—
—
—
0
0
48
274
1.80
3.50
3.3
2.4
4.05
3.74
g/l
0.29
41
252
48
274
1.80
3.50
3.3
2.4
4.22
4.19
g/l
0.07
41
252
48
274
1.80
3.50
3.3
2.4
7.44
7.31
g/l
0.20
41
252
246
1993
1.34
3.47
5.6
4.0
0.00
0.01
estimate
1.15
98
706
125
905
1.45
3.44
2.4
2.5
183.70
120.14
ug/g
0.59
107
722
17
64
2.69
3.41
1.1
1.0
—
—
—
0
0
374
3234
1.30
3.25
3.4
3.1
124.12
122.79
ug/l
0.04
342
3030
282
2355
1.31
3.16
4.3
3.4
7.27
7.74
mmol/l
1.00
251
2011
34
182
1.91
3.05
4.7
3.3
2.61
1.96
index
0.40
23
104
13
45
2.92
3.03
4.3
3.5
0.77
0.91
index
0.44
13
45
35
191
1.87
2.97
1.4
1.3
—
—
—
0
0
467
4187
1.28
2.94
3.4
3.2
—
—
—
0
0
43
698
0.59
2.85
1.6
2.0
3.85
3.52
ratio
0.58
30
563
690
6546
1.43
2.84
31.0
16.2
25.71
24.63
mg/l
0.40
639
5398
23
110
2.12
2.81
1.2
1.2
7.69
5.67
u/ml
0.22
13
51
15
59
2.57
2.80
1.1
1.0
—
—
—
0
0
37
210
1.80
2.79
1.2
1.4
304.39
295.17
ug/g
0.09
18
129
40
234
1.75
2.74
3.1
2.3
97.57
90.84
%
1.11
40
227
9
229
0.39
2.71
1.2
1.1
1.45
1.53
g/l
—
9
229
97
701
1.44
2.71
5.0
3.4
—
—
—
0
0
41
243
1.72
2.69
3.9
2.7
1.76
1.16
g/l
0.31
33
217
157
1233
1.34
2.67
1.3
1.3
29.72
31.72
iu/ml
0.08
47
373
43
261
1.68
2.60
3.5
2.5
3.16
2.97
g/l
0.42
36
239
31
171
1.85
2.58
1.1
1.2
—
—
—
0
0
196
1601
1.30
2.51
5.9
4.0
1.02
1.02
kg/l
0.41
137
1071
8
21
3.84
2.46
1.1
1.1
—
—
—
0
0
261
2216
1.27
2.46
4.7
4.2
9.26
9.44
mg/mmol
0.02
175
1406
36
212
1.73
2.43
3.7
2.6
0.00
0.02
g/l
0.50
31
194
28
154
1.85
2.37
4.0
3.1
7.99
7.62
mmol/l
0.23
28
148
7
17
4.14
2.36
2.0
2.4
29.69
18.08
umol/l
—
7
17
35
208
1.71
2.30
3.8
2.6
0.00
0.00
g/l
-0.00
30
182
40
248
1.65
2.26
1.5
1.3
—
—
—
0
0
31
512
0.59
2.23
1.4
1.8
4.01
3.45
mmol/l
1.11
19
380
14
60
2.36
2.23
5.2
2.7
741.07
808.13
mg
0.09
14
60
11
41
2.71
2.21
1.5
2.5
—
—
—
0
0
142
1130
1.31
2.20
1.3
1.3
9.51
10.40
u/ml
0.06
56
433
12
48
2.52
2.19
1.3
1.8
—
—
—
0
0
9
30
3.02
2.15
2.1
3.1
—
63344.71
—
0
7
24
131
1.86
2.10
4.8
3.2
0.86
0.88
nmol/l
0.08
18
110
10
37
2.72
2.07
1.3
1.1
—
—
—
0
0
8
26
3.10
2.01
1.6
2.0
—
—
—
0
0
8
26
3.10
2.01
1.6
2.0
—
—
—
0
0
545
5082
1.23
2.01
5.0
4.3
14.92
14.81
pmol/l
0.50
505
4643
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
8
27
2.98
1.94
2.4
2.0
—
—
—
0
0
6
16
3.77
1.93
1.2
1.1
—
—
—
0
0
51
350
1.49
1.90
1.1
1.0
—
—
—
0
0
11
238
0.45
1.89
1.6
1.1
0.77
0.90
g/l
1.03
11
238
7
22
3.20
1.88
6.1
3.8
5.35
4.73
kpa
—
7
22
7
22
3.20
1.88
6.1
3.8
11.34
10.22
kpa
—
7
22
20
107
1.89
1.87
1.3
1.2
12.00
4.58
u/ml
—
6
38
17
86
2.00
1.86
3.5
2.7
1.19
1.19
mmol/l
0.00
17
86
17
86
2.00
1.86
1.4
1.5
—
—
—
0
0
17
86
2.00
1.86
1.4
1.5
—
—
—
0
0
36
230
1.59
1.85
7.9
4.5
1.55
1.49
mg/l
0.19
36
206
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
192
1622
1.24
1.84
1.4
1.3
2.69
1.37
u/ml
0.33
45
447
5
12
4.19
1.82
1.4
1.3
—
—
—
0
0
19
101
1.90
1.82
1.0
1.1
—
—
—
0
0
17
87
1.98
1.81
1.4
1.5
—
—
—
0
0
8
29
2.78
1.79
1.0
1.1
—
—
—
0
0
17
88
1.95
1.76
3.5
2.6
4.08
4.03
mmol/l
0.19
17
88
17
88
1.95
1.76
3.5
2.6
106.53
105.43
mmol/l
0.48
17
88
9
36
2.52
1.74
3.0
2.3
—
—
—
0
0
17
89
1.93
1.71
1.3
1.5
—
—
—
0
0
689
6636
1.30
1.71
33.6
19.0
138.95
139.65
mmol/l
8.09
679
6510
68
506
1.38
1.67
2.8
2.6
74.97
66.44
ml/min/173m2
0.76
29
218
15
76
1.99
1.65
1.5
2.8
27.50
19.95
mg/l
—
6
32
689
6642
1.30
1.65
33.5
19.2
3.96
3.98
mmol/l
0.60
677
6500
47
329
1.46
1.62
2.1
1.5
0.45
0.32
mg/l
0.51
21
147
5
14
3.59
1.61
2.8
1.1
1.05
1.23
mmol/l
—
5
8
101
802
1.30
1.61
4.7
4.8
31.68
31.99
%
0.09
68
532
17
91
1.89
1.61
1.4
1.5
—
—
—
0
0
17
91
1.89
1.61
1.4
1.5
—
—
—
0
0
15
77
1.97
1.60
3.2
4.1
—
—
—
0
0
244
2752
0.84
1.54
2.1
1.9
1.41
1.35
mmol/l
0.58
200
2329
21
123
1.73
1.52
5.9
3.2
9.15
9.35
pmol/l
0.03
21
123
6
21
2.87
1.51
2.8
1.4
—
—
—
0
0
9
37
2.45
1.48
1.2
1.1
—
—
—
0
0
632
6056
1.22
1.44
6.1
5.3
1.82
1.90
mu/l
0.89
586
5600
9
40
2.26
1.40
1.2
1.4
—
—
—
0
0
9
40
2.26
1.40
1.2
1.4
—
—
—
0
0
11
54
2.05
1.33
1.4
1.3
—
79.50
—
0
6
627
6496
0.83
1.30
5.9
5.7
2.58
2.69
mmol/l
2.37
573
6046
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
8
35
2.30
1.27
1.3
1.4
—
—
—
0
0
8
35
2.30
1.27
1.3
1.4
—
—
—
0
0
35
245
1.45
1.25
2.2
2.3
163.10
3973.16
u/l
—
9
101
614
6367
0.84
1.24
5.2
4.9
1.36
1.45
mmol/l
5.89
556
5919
91
741
1.26
1.23
12.2
7.0
—
—
—
0
0
147
1261
1.20
1.22
1.5
1.6
—
—
—
0
0
9
171
0.52
1.19
1.4
1.5
—
—
—
0
0
25
165
1.53
1.19
2.0
2.4
63.78
90.17
ug/min
0.20
14
99
11
57
1.94
1.17
1.4
2.1
14.47
21.29
nmol/l
2.54
11
52
11
57
1.94
1.17
2.5
1.7
2.60
2.13
u/field
—
5
30
32
228
1.42
1.07
3.6
2.5
3.84
3.44
g/l
0.60
32
217
10
52
1.93
1.06
1.4
1.3
—
—
—
0
0
10
52
1.93
1.06
1.4
1.3
—
—
—
0
0
620
6402
0.85
1.05
5.2
5.1
4.45
4.58
mmol/l
2.30
566
5983
31
221
1.42
1.04
1.3
1.3
10.36
9.27
u/l
0.12
26
171
19
122
1.57
1.03
1.6
1.7
—
—
—
0
0
34
247
1.39
1.03
1.4
1.7
—
—
—
0
0
21
139
1.52
1.01
1.0
1.2
0.12
1.70
u/ml
3.53
13
76
31
224
1.40
0.98
1.2
1.3
200.60
247.70
miu/ml
0.30
15
109
15
92
1.64
0.97
1.1
1.2
—
—
—
0
0
7
36
1.95
0.97
1.0
1.3
18.71
9.47
mm/h
—
7
36
12
70
1.73
0.93
1.2
1.2
—
—
titre
—
0
0
26
184
1.43
0.92
1.9
1.8
2.77
4.62
iu/l
—
9
70
9
52
1.74
0.92
1.0
1.2
113.44
102.27
pmol/l
—
9
52
8
42
1.91
0.88
1.6
1.5
—
1020533.17
iu/ml
—
0
6
640
6214
1.16
0.88
25.4
15.5
82.51
81.64
ml/min/173m2
0.42
613
5730
28
207
1.37
0.80
1.3
1.2
—
—
—
0
0
13
199
0.65
0.79
1.1
1.5
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
8.71
—
0
26
28
208
1.36
0.78
1.2
1.2
—
—
—
0
0
18
123
1.47
0.78
1.1
1.1
11.95
3.83
u/ml
0.72
11
72
6
34
1.77
0.76
9.7
3.4
0.75
0.85
%
—
6
34
10
59
1.70
0.76
1.3
1.2
3173.00
338182.14
e6/l
—
5
42
84
965
0.86
0.67
1.5
1.5
—
—
—
0
0
7
43
1.63
0.67
1.9
1.5
—
—
—
0
0
37
299
1.25
0.60
1.4
1.4
24.52
23.37
iu/l
0.07
29
244
8
52
1.54
0.59
1.8
1.7
12.35
12.52
umol/l
—
8
47
536
5515
0.91
0.57
34.5
20.7
332.29
332.58
g/l
0.27
530
5484
6
38
1.58
0.54
1.3
1.9
174.33
108.64
ng/l
—
6
38
9
65
1.39
0.50
6.3
2.2
13.06
13.06
%
—
9
65
13
93
1.40
0.48
1.2
1.1
—
—
—
0
0
701
6911
1.13
0.48
34.9
20.8
81.98
78.17
umol/l
1.01
696
6826
45
385
1.18
0.45
1.9
2.0
—
—
—
0
0
9
130
0.69
0.43
2.0
1.7
—
—
—
0
0
16
123
1.31
0.40
1.1
1.1
0.61
2.24
u/ml
—
10
65
8
60
1.34
0.40
2.0
1.5
—
—
—
0
0
13
98
1.33
0.37
1.0
1.1
—
2.27
—
0
19
8
114
0.70
0.37
1.4
1.5
45.90
54.09
ug/l
—
8
114
5
37
1.35
0.37
2.6
1.9
27.20
29.19
umol/l
—
5
32
9
71
1.27
0.36
2.0
3.3
4.07
5.53
nmol/l
—
9
71
601
6109
0.93
0.35
4.4
4.2
1.39
1.28
mmol/l
2.40
541
5638
6
45
1.34
0.34
1.3
1.3
—
—
—
0
0
707
7134
0.91
0.30
41.3
24.6
132.32
135.50
g/l
6.96
701
7061
29
250
1.17
0.30
1.6
1.7
15.68
9.24
u/ml
—
6
54
707
7131
0.92
0.28
41.9
24.9
39.43
40.43
%
5.16
700
7053
707
7131
0.92
0.28
40.9
24.4
4.42
4.51
e12/l
4.21
695
6982
694
6872
1.08
0.28
17.1
12.0
26.41
26.55
u/l
0.08
676
6692
707
7129
0.92
0.27
40.9
24.4
90.80
90.93
fl
0.31
700
7057
12
150
0.80
0.27
1.6
1.6
—
—
—
0
0
707
7128
0.92
0.26
41.0
24.5
253.40
248.44
e9/l
1.07
697
6995
8
67
1.20
0.26
2.4
1.7
—
—
—
0
0
76
705
1.09
0.25
3.4
4.5
4.25
27.37
ug/l
1.30
65
592
124
1309
0.94
0.25
3.8
3.1
0.70
0.76
ug/l
0.38
88
823
81
755
1.08
0.24
2.2
2.1
—
—
—
0
0
12
96
1.25
0.24
4.5
1.9
33.83
33.09
pg
0.25
12
96
57
523
1.10
0.24
1.4
1.4
—
—
—
0
0
88
824
1.08
0.24
2.4
2.2
—
—
—
0
0
170
1774
0.95
0.24
4.4
4.5
21.73
21.55
%
0.04
79
819
13
158
0.82
0.23
1.3
1.3
—
—
—
0
0
5
39
1.28
0.23
1.2
1.3
41.20
17.27
u/l
—
5
33
5
41
1.22
0.22
1.2
2.0
—
—
—
0
0
5
41
1.22
0.22
1.2
2.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.06
—
0
5
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
2.61
—
0
6
0
12
0.00
0.21
0.0
1.0
—
0.01
—
0
6
28
249
1.13
0.21
1.8
2.0
43.46
38.43
nmol/l
0.47
28
235
604
6106
0.95
0.21
7.5
6.3
41.30
39.25
mmol/mol
4.72
561
5742
620
6247
0.96
0.14
5.5
5.0
6.15
5.94
mmol/l
2.54
555
5732
49
462
1.06
0.13
1.9
2.1
—
—
—
0
0
37
348
1.07
0.10
1.2
1.3
—
—
—
0
0
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
5
48
1.04
0.09
1.4
1.5
—
24.71
—
0
7
218
2214
0.98
0.08
5.4
5.4
2.52
2.47
ug/l
0.03
201
1991
9
86
1.05
0.07
1.4
1.6
—
—
—
0
0
20
214
0.93
0.07
1.5
1.5
—
—
—
0
0
20
189
1.06
0.04
1.5
1.4
—
—
—
0
0
28
288
0.97
0.02
3.6
3.5
865.39
4936.65
u/ml
0.63
23
253
12
113
1.06
0.02
1.2
1.5
—
—
—
0
0
46
457
1.01
0.00
1.2
1.2
82.84
150.18
u/ml
1.34
15
176
0
6
0.00
0.00
0.0
1.0
—
48.67
—
0
6
0
8
0.00
0.00
0.0
1.0
—
0.63
—
0
8
0
6
0.00
0.00
0.0
1.2
—
10.67
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
76.44
—
0
9
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_ENCEPHALITIS_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_ENCEPHALITIS_NOS | 2.464 [2.09, 2.9] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.08 |
During the follow-up period (1.1.1998 — 31.12.2019), 682 out of 2632 females with AB1_VIRAL_ENCEPHALITIS_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_ENCEPHALITIS_NOS | 2.368 [2.0, 2.8] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.027 |
During the follow-up period (1.1.1998 — 31.12.2019), 697 out of 2910 males with AB1_VIRAL_ENCEPHALITIS_NOS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_ENCEPHALITIS_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.192% | 0.38% |
| 5 | 1.417% | 2.691% |
| 10 | 3.442% | 7.213% |
| 15 | 6.084% | 13.363% |
| 20 | 10.659% | 21.966% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_ENCEPHALITIS_NOS – Viral encephalitis, not elsewhere classified/unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data